Headline Surprise vs. Forecast
Our forecast for January 2026 CPI was +0.25% month-over-month,
equivalent to roughly 3.00%–3.04% annualized,
explicitly stated as “subject to the effects of the tariff increase.”
The Bureau of Labor Statistics (BLS) instead reported
+0.38% month-over-month, equivalent to
4.56%–4.65% annualized.
The surprise was significant — particularly because the increase did
not originate from the traditional inflation drivers
such as gasoline or mortgage-related components.
Monthly Sector Contributions (MoM)
- Food: +0.56%
- Dairy and related products: +0.83%
- Energy – Electricity: +1.56%
- Hospitals: +0.92%
- Medicare (drugs): +0.52%
- Import-heavy sectors: Broad increases
Electricity deserves special attention. Strong demand from
technology hyper-centers and AI infrastructure
has increased natural gas and uranium demand, pushing power prices higher.
Core Index Signals
- All items less medical care: +0.357%
- All items less food, shelter, energy, and used cars/trucks: +0.758%
The second figure is particularly important. When stripping out
volatile components, the increase remains elevated — with healthcare
as a dominant contributor.
Import Price Dynamics – Food Sector
Canada and Latin America are key agricultural import partners.
Monthly import price changes show mixed but generally moderate movements:
- Canada – Agriculture: -1.611%
- Canada – Food Manufacturing: -2.251%
- Latin America – Agriculture: +0.341%
- Latin America – Crop Production: +0.737%
- Latin America – Fruit & Tree Nut Farming: +1.876%
- Mexico – Agriculture: +0.284%
- Mexico – Crop Production: +1.845%
The United States has structurally reduced its nonfarm and agricultural
production base over the last 25 years. When domestic consumption rises
while domestic production falls, dependency on imports increases.
In such an environment, even minor speculative behavior or supply
constraints can lift prices quickly.
Applying tariffs to agricultural imports — a sector with immediate
CPI transmission — mechanically raises end-consumer prices.
Chemical & Pharmaceutical Imports
- Canada – Pharmaceutical manufacturing: -1.829%
- European Union – Pharmaceutical manufacturing: -0.083%
- Industrialized Countries: +0.079%
- India – Pharmaceutical manufacturing: +0.21%
Import prices in pharmaceuticals do not show
significant inflationary pressure. However, domestic producers and
distributors appear to be applying expected future tariffs
to pricing structures in advance — a speculative pricing maneuver.
Tariffs: Fiscal Gain vs. Price Stability
We have already observed that tariff increases contributed meaningfully
to the improvement in the first four months of the FY 2025–2026
Treasury deficit position.
However, this fiscal improvement appears to be partially offset by
upward CPI pressure — amplified not only by structural import exposure
but also by anticipatory pricing behavior.
The effect of tariffs — applied by country rather than by targeted sector —
is beginning to surface in consumer pricing.
Policy Implications
This CPI report is negative from a monetary policy perspective.
It dampens any near-term reasoning for rate cuts and reinforces
restrictive conditions.
The market, for now, does not appear to be fully pricing this structural
shift. However, when combined with mixed macro data, the cumulative effect
could become materially negative for the broader economic system.